HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anna Merlo Selected Research

ONCOFID-S

1/2015Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anna Merlo Research Topics

Disease

17Neoplasms (Cancer)
01/2017 - 09/2008
3Paraganglioma (Paragangliomas)
01/2017 - 11/2012
3Carcinoma (Carcinomatosis)
01/2017 - 01/2014
2Heart Failure
01/2024 - 06/2023
2Hypoxia (Hypoxemia)
01/2017 - 08/2015
2Ovarian Neoplasms (Ovarian Cancer)
01/2016 - 01/2015
2Squamous Cell Carcinoma of Head and Neck
08/2015 - 03/2013
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
05/2024
1Polycythemia Vera
12/2023
1Polycythemia (Erythrocytosis)
12/2023
1Glioblastoma (Glioblastoma Multiforme)
01/2022
1Graft vs Host Disease (Graft-Versus-Host Disease)
11/2020
1COVID-19
11/2020
1Inflammation (Inflammations)
01/2015
1Peritoneal Neoplasms
01/2014
1Carcinogenesis
03/2013
1Neurofibromatoses (Neurofibromatosis)
01/2013
1Neurofibrosarcoma (MPNST)
01/2013
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
08/2012
1Lymphoma (Lymphomas)
08/2012
1Virus Diseases (Viral Diseases)
03/2011
1Melanoma (Melanoma, Malignant)
12/2009

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
01/2017 - 08/2012
3MicroRNAs (MicroRNA)IBA
01/2017 - 11/2012
3Messenger RNA (mRNA)IBA
01/2017 - 01/2013
3AntigensIBA
01/2017 - 12/2009
2Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2017 - 10/2013
2Small Interfering RNA (siRNA)IBA
01/2017 - 03/2013
2Hyaluronic Acid (Hyaluronan)IBA
01/2015 - 01/2014
2Irinotecan (Camptosar)FDA LinkGeneric
01/2015 - 01/2014
2CytokinesIBA
01/2014 - 12/2009
1obinutuzumabIBA
05/2024
1Losartan (Cozaar)FDA LinkGeneric
12/2023
1Enalaprilat (Vasotec)FDA LinkGeneric
12/2023
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
12/2023
1Biomarkers (Surrogate Marker)IBA
06/2023
1Temozolomide (Temodar)FDA LinkGeneric
01/2022
1Dry IceIBA
11/2020
1EnzymesIBA
01/2017
1Monoclonal AntibodiesIBA
01/2017
1Interferon-alpha (Interferon Alfa)IBA
01/2016
1Gefitinib (Iressa)FDA Link
08/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2015
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
08/2015
1ErbB Receptors (EGF Receptor)IBA
08/2015
1Type I DNA Topoisomerases (Topoisomerase I)IBA
01/2015
1ONCOFID-SIBA
01/2015
1Caspase 3 (Caspase-3)IBA
01/2015
1LuciferasesIBA
01/2014
1Paclitaxel (Taxol)FDA LinkGeneric
01/2014
1CaveolinsIBA
01/2014
1TRPC6 Cation ChannelIBA
03/2013
1SurvivinIBA
01/2013
1sulofenur (ISCU)IBA
11/2012
1IronIBA
11/2012
1SulfurIBA
11/2012
1Cancer VaccinesIBA
08/2012
1VaccinesIBA
08/2012
1Myc associated factor XIBA
05/2012
1MetanephrineIBA
05/2012
1NormetanephrineIBA
05/2012
1Chimeric Antigen ReceptorsIBA
03/2011
1DecitabineFDA Link
05/2010
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2009
1Therapeutic UsesIBA
12/2009
1MART-1 AntigenIBA
12/2009

Therapy/Procedure

6Therapeutics
01/2024 - 09/2008
2Immunotherapy
03/2011 - 12/2009
1Ligation
10/2013
1Cell- and Tissue-Based Therapy (Cell Therapy)
09/2008